Suchergebnisse - (Subject:"Tocilizumab")

PubPharm (6.672)

1

Assessment of the effectiveness of tocilizumab on mortality and progression to mechanical ventilation or intensive care in patients with COVID-19 admitted to a tertiary hospital

enthalten in: European journal of hospital pharmacy : science and practice | 2024

von Pinilla Rello, A. | Magallón Martínez, A. | Vicente Iturbe, C. | +3

2

The First Case of a Korean Patient with a Mutation-Confirmed Tumor Necrosis Factor Receptor-Associated Periodic Syndrome

enthalten in: Yonsei medical journal | 2024

von Lee, S. | Baek, J. | Lee, J. | +2

3

Impaired IL-6-induced JAK-STAT signaling in CD4+ T cells associates with longer treatment duration in giant cell arteritis

enthalten in: Journal of autoimmunity | 2024

von Esen, I. | Sandovici, M. | Heeringa, P. | +4

4

Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease : A post hoc analysis from the focuSSced trial

enthalten in: Seminars in arthritis and rheumatism | 2024

von Bernstein, E. | Denton, C. | Huang, S. | +1

5

Serum IL-6 level trajectory for predicting the effectiveness and safety of tocilizumab in the treatment of refractory Takayasu arteritis

enthalten in: European journal of internal medicine | 2024

von Sun, X. | Fang, C. | Jin, S. | +4

6

Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia

enthalten in: Clinical rheumatology | 2024

von An, Q. | Ma, R. | Yuan, D. | +8

7

Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant thyroid eye disease : a prospective study

enthalten in: International ophthalmology | 2024

von Lee, C. | Park, J. | Kim, Y. | +1

8

Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant thyroid eye disease: a prospective study

enthalten in: International ophthalmology | 2024

von Lee, C. | Park, J. | Kim, Y. | +1

9

Tocilizumab Versus Baricitinib for the Treatment of COVID-19 in Patients With Obesity

enthalten in: Journal of pharmacy practice | 2024

von Troyer, B. | Kovacic Scherrer, N. | Garavaglia, J.

10

Tocilizumab for refractory post-COVID-19 pansclerotic morphea

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Saraswat, N. | Tripathy, D. | Mishra, A. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[668]